Effects of Intranasal Ketamine on Depression and Anxiety in Palliative Care Cancer Patients

Clinical trial NCT06665568 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06665568
Sponsor: University of Zurich
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Depressive Symptoms Mild to Moderate in Severity Anxiety Quality of Life (QOL)Caregiver Burden Sleep Quality

Start date: 2025-04-01
Primary completion: 2025-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.